# Hydrogen's Feasibility and Safety as a Therapy in ECPR

> **NCT05574296** · PHASE1 · RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 53 (estimated)

## Conditions studied

- Cardiac Arrest
- Extracorporeal Membrane Oxygenation
- Reperfusion Injury

## Interventions

- **DRUG:** Hydrogen
- **OTHER:** Usual care

## Key facts

- **NCT ID:** NCT05574296
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-04
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05574296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05574296, "Hydrogen's Feasibility and Safety as a Therapy in ECPR". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05574296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*